Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Experience from Asian Centers in a Named-Patient-use Program for Afatinib in Patients with Advanced Non-Small-cell Lung Cancer Who Had Progressed Following Prior Therapies, Including Patients with Uncommon EGFR Mutations

Chung Shan Medical University,Lam David Chi-Leung,Tsai Chun-Ming,Chen Yuh-Min,Shih Jin-Yuan,Aggarwal Shyam,Wang Shuhang,Kim Sang-We,Kim Young-Chul, Wahid Ibrahim,Li Rubi,Lim Darren Wan-Teck,Sriuranpong Virote,Chan Raymond Tsz-Tong,Lorence Robert M.,Carriere Philippe,Raabe Christina,Cseh Agnieszka,Park Keunchil

International Journal of Clinical Oncology（2021）

Cited 4|Views9
Key words
Afatinib,HER2 mutations,Lung cancer,Named patient use,NSCLC,Uncommon EGFR mutations
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined